United States
US 12,697,371 B2
Method for preventing, treating or delaying myocardial damage using neuregulin and composition
US 12,697,371 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD.
- Inventors
- Mingdong ZHOU
- Publication date
- 2026-08-04
- Filing date
- 2021-07-06
- Document type
- B2 Granted patent
- Also written as
- US 12,697,371 B2 · US12697371 · 12697371
Abstract
A method for preventing, treating or delaying myocardial damage in a mammal using neuregulin and a composition. An administration method for, an administration frequency of and an administration dosage of a pharmaceutical formulation or composition for reducing myocardial damage. It can be proved in a rat myocardial damage model that neuregulin can improve the cardiac function after myocardial infarction, suggesting that neuregulin can be used for preventing, treating, or delaying myocardial infarction damage.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free